Nuvation Bio: Looking forward to further developing Taletrectinib and plans to share the results of key global Trust-II research by the end of 2024
Nuvation Bio：期待进一步推进Taletrectinib的发展并计划在2024年底之前分享全球关键性Trust-II研究的结果
Nuvation Bio: Looking forward to further developing Taletrectinib and plans to share the results of key global Trust-II research by the end of 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.